Patients who responded to gemcitabine also had longer MST than those who did not respond to the regimen (12.3 versus 8.2 moths; Figure 7 B ) although the difference did not reach statistical significance ( P log-rank =0.175) probably due to limited sample size.
← all excerpts
Functional role of BTB and CNC Homology 1 gene in pancreatic cancer and its association with survival in patients treated with gemcitabine.
1
—
—